Bourla Albertinsider trades
In SEC Form 4 filings, Bourla Albert is listed as Chairman & CEO of Pfizer Inc (PFE). Bourla Albert reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PFEPfizer Inc | Chairman & CEO | 5 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PFEPfizer Inc | Oct 15 | Oct 16 | A · derivative | 20 | $29.44 | $589 | 783,997 | No | Form 4 |
| PFEPfizer Inc | Oct 13 | Oct 14 | A · derivative | 71 | $28.37 | $2,014 | 783,981 | No | Form 4 |
| PFEPfizer Inc | Sep 30 | Oct 1 | A · derivative | 21 | $28.52 | $599 | 783,888 | No | Form 4 |
| PFEPfizer Inc | Sep 15 | Sep 16 | A · derivative | 22 | $27.55 | $606 | 783,985 | No | Form 4 |
| PFEPfizer Inc | Aug 31 | Sep 1 | A · derivative | 21 | $28.46 | $598 | 784,012 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.